MedinCell SA (MEDCL):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:MedinCell SA (MEDCL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10787
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MedinCell SA (MedinCell) is a developer of therapeutic solutions for the healthcare market. The company develops and commercializes BEPO, a technology based on custom proprietary copolymers and a biocompatible solvent for long acting injectables. Its BEPO provides a controlled release of therapeutic molecules and can be used to improve the treatment for a variety of chronic diseases or short-term illnesses. MedinCell provides peptides and proteins delivery services. MedinCell offers products for various indications including schizophrenia, pain and inflammation, depression, anaesthesia, organ transplant, and others. The company works for profit and non-profit projects, and collaborates with partners including pharmas, physicians, biotech firms, academics and foundations. MedinCell is headquartered in Jacou, France.

MedinCell SA (MEDCL) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MedinCell SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MedinCell SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MedinCell SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MedinCell SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
MedinCell SA, Medical Devices Deals, 2012 to YTD 2018 9
MedinCell SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
MedinCell SA, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
MedinCell Raises Funds through Financing 11
Partnerships 12
MedinCell Enters into Agreement with Sandoz International 12
Corbion and MedinCell Form Joint Venture 13
Equity Offering 14
MedinCell Raises USD34.9 Million in IPO 14
MedinCell SA – Key Competitors 15
MedinCell SA – Key Employees 16
MedinCell SA – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Corporate Communications 18
Jul 06, 2017: Dr. Sabri Markabi Joins MedinCell’s Supervisory Board 18
Product News 19
12/07/2017: MedinCell receives grant to develop long-acting injectable contraceptive 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
MedinCell SA, Pharmaceuticals & Healthcare, Key Facts 2
MedinCell SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MedinCell SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MedinCell SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MedinCell SA, Deals By Therapy Area, 2012 to YTD 2018 8
MedinCell SA, Medical Devices Deals, 2012 to YTD 2018 9
MedinCell SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
MedinCell Raises Funds through Financing 11
MedinCell Enters into Agreement with Sandoz International 12
Corbion and MedinCell Form Joint Venture 13
MedinCell Raises USD34.9 Million in IPO 14
MedinCell SA, Key Competitors 15
MedinCell SA, Key Employees 16
MedinCell SA, Other Locations 17
MedinCell SA, Subsidiaries 17

List of Figures
MedinCell SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
MedinCell SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
MedinCell SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
MedinCell SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
MedinCell SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MedinCell SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
MedinCell SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MedinCell SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
MedinCell SA, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[MedinCell SA (MEDCL):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Groupe Caisse d’Epargne:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Groupe Caisse d'Epargne Mergers …
  • BP Plc (BP.):電力:M&Aディール及び事業提携情報
    Summary BP Plc (BP) is an integrated oil and gas company. Its upstream activities include exploration, development and production of oil and natural gas, field development and production; and midstream operations include transportation, and marketing and trading of natural gas, including liquefied n …
  • Maverick Natural Resources LLC:企業の戦略的SWOT分析
    Maverick Natural Resources LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • HCL Technologies Ltd (HCLTECH):企業の財務・戦略的SWOT分析
    HCL Technologies Ltd (HCLTECH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • InTouch Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary InTouch Technologies Inc (InTouch Health) is a healthcare technology company that provides Telehealth Network, comprised of telehealth systems, clinical workflow solutions, software and managed services to healthcare systems and hospitals for the delivery of clinical care. The company’s tele …
  • Wuxi Pharmatech (Cayman) Inc:企業の戦略・SWOT・財務分析
    SummaryWuxi Pharmatech (Cayman) Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company …
  • Ecobliss Holding BV:企業の戦略・SWOT・財務情報
    Ecobliss Holding BV - Strategy, SWOT and Corporate Finance Report Summary Ecobliss Holding BV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Innospec Inc (IOSP):石油・ガス:M&Aディール及び事業提携情報
    Summary Innospec Inc (Innospec) is a provider of specialty chemicals. It blends, manufactures and supplies fuel additives and other specialty chemicals. Innospec’s product portfolio includes stabilizers, detergents, cold flow improvers, lubricity improvers, corrosion inhibitors, conductivity improve …
  • Acme Resources Inc. (ARI):企業概要、財務及び戦略的SWOT分析
    Summary Acme Resources Inc. (Acme Resources) is a mineral exploration company. The company provides acquisition, exploration, and advancement of mineral properties in Canada. Its products include uranium, copper, gold, and rare earth elements. The company explores and develops uranium and base metal …
  • Jorudan Co.,Ltd. (3710):企業財務及び戦略的SWOT分析
    Summary Jorudan Co.,Ltd. (Jorudan) is an information technology company that develops software applications. The company's products include ASAYOMU, dokusho no jikan, AD norikaeannai, norikaeannai complete, norikaeannai intranet, norikaeannai macx, norikaeannai next, noriakeannai premium, hamster cl …
  • Mecc Alte S.p.a.:企業の戦略的SWOT分析
    Mecc Alte S.p.a. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Amgen, Inc.:企業の戦略・SWOT・財務分析
    SummaryAmgen, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - …
  • Vifor Pharma AG(製薬・医療分野):企業M&A動向
    Summary Vifor Pharma AG (Vifor Pharma) is a pharmaceutical company. The company discovers, develops and manufactures prescription and over-the-counter (OTC) pharmaceutical products. It offers its products for use in the areas of renal and infectious diseases, iron deficiency and consumer healthcare. …
  • LeMaitre Vascular Inc (LMAT):医療機器:M&Aディール及び事業提携情報
    Summary LeMaitre Vascular Inc (LeMaitre Vascular) provides medical devices and services for the treatment of peripheral vascular diseases. The company develops, manufactures, and markets disposable and implantable devices that vascular surgeons use in arteries and veins outside the heart in open vas …
  • Oriental Yeast Co Ltd:企業の戦略・SWOT・財務分析
    SummaryOriental Yeast Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key F …
  • Den-Mat Holdings LLC:企業のM&A・提携動向(医療機器分野)
    Summary Den-Mat Holdings LLC (Den-Mat) is a medical device company that develops and manufactures dental products. The company offers products such as curing lights, finishing and polishing, impressions, instruments, lesion detection, magnification/illumination, oral hygiene, restoratives, soft tiss …
  • Core Information System Co., Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Core Information System Co., Lt …
  • A.P. Eagers Limited:企業の戦略・SWOT・財務情報
    A.P. Eagers Limited - Strategy, SWOT and Corporate Finance Report Summary A.P. Eagers Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Juhl Energy, Inc. (JUHL):企業のM&A・提携動向(発電分野)
    Summary Juhl Energy, Inc. (Juhl Energy), formerly Juhl Wind, Inc., is specialized in the clean and renewable-energy industry. It offers a wide range of clean energy solutions with a focus on solar, wind, biomass and natural gas systems. The company pioneered community-based wind farms. It services e …
  • Skyline Diagnostics BV:(医療機器分野)企業M&A及び提携動向
    Summary Skyline Diagnostics BV (Skyline) is a biotechnology company. It discovers, develops and commercializes microarray-based diagnostic tests using molecular signatures for the treatment of blood cancers. The company utilizes Affymetrix GeneChip technology to develop in vitro diagnostic microarra …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆